Drug profile · INN
plerixafor
MOZOBIL
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
plerixafor (MOZOBIL) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
INN plerixafor
Brand MOZOBIL
Route SUBCUTANEOUS
Formulation SOLUTION
ATC code L03AX16
Originator Amneal Pharma Europe Ltd
Frequently asked questions
What is plerixafor?
plerixafor (MOZOBIL) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for plerixafor?
MOZOBIL is a marketed brand name for plerixafor. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of plerixafor?
plerixafor has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.